Kyverna Therapeutics
KYTX
#6965
Rank
S$0.78 B
Marketcap
S$13.05
Share price
5.36%
Change (1 day)
372.10%
Change (1 year)

Kyverna Therapeutics (KYTX) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : S$44.9 Million

According to Kyverna Therapeutics's latest financial reports the company's total liabilities are S$44.9 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Kyverna Therapeutics - Total liabilities on balance sheet (from 2022 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31S$51.73 M-81.04%
2023-12-31S$0.27 B44.43%
2022-12-31S$0.18 B6.07%
2021-12-31S$0.17 B